Butzke, B. et al. 2016. The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance. Acta Oncologica. 55, 3 (Mar. 2016), 318–328. DOI:https://doi.org/10.3109/0284186X.2015.1053983.